ÆüËÜÇÀ·Ý²½³Ø²ñ 2021ǯÅÙÂç²ñ¥×¥í¥°¥é¥à¸¡º÷

¥ª¥ó¥é¥¤¥óŸ¼¨²ñ (¥í¥°¥¤¥ó¤¬É¬ÍפǤ¹)
½ªÎ»¤·¤Þ¤·¤¿
¥×¥í¥°¥é¥à½¸PDF ´ë¶ÈÀâÌÀ²ñ
½ªÎ»¤·¤Þ¤·¤¿
¿Ê¹ÔÃæ¤Î¥×¥í¥°¥é¥à°ìÍ÷
½ªÎ»¤·¤Þ¤·¤¿
Âç²ñ¥È¥Ã¥×¥Ú¡¼¥¸¤ËÌá¤ë
Âç²ñ¥×¥í¥°¥é¥à½¸¡¦Âç²ñ¹Ö±éÍ׻ݽ¸¡ÎPDF¡Ï¤ÎÊѹ¹ (¹¹¿·¡§3/24)
¼ø¾Þ¼°¡¦¼õ¾Þ¹Ö±éÆ°²è¤¬¸ø³«¤µ¤ì¤Þ¤·¤¿¡£
¢¨¸ø³«´ü´Ö¡§2021ǯ5·î14Æü¡Á2022ǯ2·îËöÆü¤Þ¤Ç
¿ä¾©¥Ö¥é¥¦¥¶¡§Chrome¡¢FireFox¡¢Edge¡¢Safari
(Internet Explorer¤Ç¤ÏÀµ¤·¤¯É½¼¨¤µ¤ì¤Ê¤¤¾ì¹ç¤¬¤¢¤ê¤Þ¤¹)
2E01-01
°ìÈֱ̹é
¥ß¡¼¥Æ¥£¥ó¥°¥ë¡¼¥à E
¼«¸ÊÌȱּÀ´µ¥·¥§¡¼¥°¥ì¥ó¾É¸õ·²¤ÎÎÞ±ÕʬÈ絡ǽÄã²¼¤ËµÚ¤Ü¤¹¥Ö¥ë¡¼¥Ù¥ê¡¼ÍÕ¥¨¥­¥¹¤ÎºîÍÑ
Preventive effects of blueberry leaf extract on lacrimal secretion in incurable disease Sjögren's syndrome-model mice
¡û±ºÅÄ ²ÌÎÓ1Á°ÅÄ ºé1¾®Àî ·òÆóϺ2ÂçÌî ͺÂÀ4º´Æ£ ·ÄÂÀϺ5»³ùõ ÀµÉ×1À¾»³ ÏÂÉ×1¸åÆ£ ÍÛ3Ã滳 µ®Ç·3
¡ûKarin URATA1 Saki MAEDA1 Kenjirou OGAWA2 Yuta OHNO4 Keitaro SATOH5 Masao YAMASAKI1 Kazuo NISHIYAMA1 Yo GOTO3 Takayuki NAKAYAMA3
1µÜºêÂçÇÀ¡¢2µÜºêÂç¥Æ¥Ë¥å¥¢¥È¥é¥Ã¥¯¡¢3¥Ó¥ª¥é¥Ü¡¢4Ä«ÆüÂç»õ¡¢5ÌÀ³¤Âç»õ
1Univ. of Miyazaki, 2Tenure Track, Univ. of Miyazaki, 3Biolabo Co., Ltd., 4Asahi Univ., 5Meikai Univ.
Sjogren syndrome / lacrimal gland / blueberry leaf

Í×»ÝËÜʸ¤Ï¥È¥Ã¥×¥Ú¡¼¥¸¤«¤é¥í¥°¥¤¥ó¤ò¤·¤Æĺ¤¯¤Èɽ¼¨¤µ¤ì¤Þ¤¹¡£